<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-vaccines-07-00074">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kong</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Acharya</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lemmin</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody</article-title>
  <source>Science</source>
  <year>2016</year>
  <volume>352</volume>
  <fpage>828</fpage>
  <lpage>833</lpage>
  <pub-id pub-id-type="doi">10.1126/science.aae0474</pub-id>
  <pub-id pub-id-type="pmid">27174988</pub-id>
 </element-citation>
</ref>
